-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Labcorp Holdings Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Labcorp Holdings Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$19.5M, a 172% decline year-over-year.
- Labcorp Holdings Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$78.1M, a 430% decline from 2022.
- Labcorp Holdings Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $23.7M.
- Labcorp Holdings Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$38.4M, a 18.3% increase from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)